Cargando…
Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
BACKGROUND: Anti-epidermal growth factor receptor (EGFR) antibody is widely used for the treatment of patients with metastatic colorectal cancer. Hypomagnesemia is a comparatively frequent adverse event of this drug, which is likely overlooked because it occurs later in treatment without symptoms. F...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803608/ https://www.ncbi.nlm.nih.gov/pubmed/31637554 http://dx.doi.org/10.1186/s40792-019-0707-5 |